Seeing Is Believing
Currently out of the existing stock ratings of Daniel Brennan, 19 are a HOLD (54.29%), 13 are a BUY (37.14%), 3 are a SELL (8.57%).
Analyst Daniel Brennan, currently employed at TD COWEN, carries an average stock price target met ratio of 62.48% that have a potential upside of 17.48% achieved within 137 days.
Daniel Brennan’s has documented 239 price targets and ratings displayed on 18 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on QTRX, Quanterix Corp at 13-Nov-2024.
Analyst best performing recommendations are on NVTA (INVITAE CORP).
The best stock recommendation documented was for NVTA (INVITAE CORP) at 7/26/2022. The price target of $2 was fulfilled within 1 day with a profit of $0.06 (3.09%) receiving and performance score of 30.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$48
$9.92 (26.05%)
$57
1 months 16 days ago
(08-May-2025)
7/9 (77.78%)
$7.49 (18.49%)
145
Hold
$45
$6.92 (18.17%)
$60
1 months 16 days ago
(08-May-2025)
7/8 (87.5%)
$4.49 (11.08%)
135
Buy
$46
$7.92 (20.80%)
$50
1 months 16 days ago
(08-May-2025)
0/5 (0%)
$5.49 (13.55%)
Buy
$60
$21.92 (57.56%)
$75
2 months 7 days ago
(17-Apr-2025)
4/6 (66.67%)
$23.72 (65.38%)
255
Buy
$80
$41.92 (110.08%)
$90
6 months 11 days ago
(13-Dec-2024)
0/2 (0%)
$22.27 (38.58%)
What Year was the first public recommendation made by Daniel Brennan?